《中国眼科药物说明书外使用临床实践指南》解读  

The Clinical Practice Guideline for Off-label Drug Use in Ophthalmology in China: a executive summary

作　　者：李光耀 王宁利[2] 张玉[3] 魏文斌[2] 卢海[2] 翟所迪[4] 张弨 LI Guang-yao;WANG Ning-li;ZHANG Yu;WEI Wen-bin;LU Hai;ZHAI Suo-di;ZHANG Chao(Department of Pharmacy,Beijing 100730,China;Beijing Tongren Eye Center,Beijing Key Laboratory of Ophthalmology and Visual Science,Beijing Tongren Hospital,Capital Medical University,Beijing 100730,China;Department of Pharmacy,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Pharmacy,Peking University Third Hospital,Beijing 100191,China)

机构地区：[1]首都医科大学附属北京同仁医院药学部,北京100730 [2]北京同仁眼科中心北京市眼科学与视觉科学重点实验室,北京100730 [3]华中科技大学同济医学院附属协和医院药学部,武汉430022 [4]北京大学第三医院药剂科,北京100191

出　　处：《临床药物治疗杂志》2022年第9期28-36,共9页Clinical Medication Journal

摘　　要：《中国眼科药物说明书外使用临床实践指南》是由首都医科大学附属北京同仁医院药学部发起,北京同仁医院、中国药学会医院药学专业委员会、中国医药教育协会、中国医师协会眼科医师分会及中国老年保健医学研究会共同支持制定的临床实践指南。该指南严格按照世界卫生组织指南制定手册,针对25个眼科药物说明书外使用问题,最终形成强推荐意见5条、弱推荐意见27条。指南于2022年5月发表于Frontiers in Pharmacology。本文为该指南的中文解读版本,涵盖本部指南所有推荐意见、证据解读,旨在为眼科药物说明书外使用提供参考。The Clinical Practice Guideline for Off-label Drug Use in Ophthalmology in China was launched by Department of Pharmacy,Beijing Tongren Hospital,Capital Medical University,supported by the Hospital Pharmacy Professional Committee of the Chinese Pharmaceutical Society,China Medicine Education Association,Ophthalmology Doctor Association of Chinese Medical Doctor Association,and Chinese Association of Geriatric Research. The guideline presented 5 strong recommendations and 27 weak recommendations to address 25 clinical questions,following the WHO Handbook for guideline development. The guideline has been published in Frontiers in Pharmacology in May 2022. This article is the Chinese interpretation version of the guideline,covering all recommendations,evidence,aiming to provide reference for the off-label use of ophthalmic drugs.

关 键 词：临床实践指南 眼科用药 药物说明书外使用 合理用药 

分 类 号：R988.1[医药卫生—药品]